GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (STU:BJX1) » Definitions » Shiller PE Ratio

BioLife Solutions (STU:BJX1) Shiller PE Ratio : (As of Jul. 23, 2025)


View and export this data going back to 2017. Start your Free Trial

What is BioLife Solutions Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


BioLife Solutions Shiller PE Ratio Historical Data

The historical data trend for BioLife Solutions's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions Shiller PE Ratio Chart

BioLife Solutions Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioLife Solutions Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BioLife Solutions's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, BioLife Solutions's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLife Solutions's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BioLife Solutions's Shiller PE Ratio falls into.


;
;

BioLife Solutions Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BioLife Solutions's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, BioLife Solutions's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.009/134.9266*134.9266
=-0.009

Current CPI (Mar. 2025) = 134.9266.

BioLife Solutions Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 -0.071 100.684 -0.095
201509 -0.080 100.392 -0.108
201512 -0.083 99.792 -0.112
201603 -0.090 100.470 -0.121
201606 -0.098 101.688 -0.130
201609 -0.071 101.861 -0.094
201612 -0.246 101.863 -0.326
201703 -0.065 102.862 -0.085
201706 -0.053 103.349 -0.069
201709 -0.025 104.136 -0.032
201712 -0.042 104.011 -0.054
201803 -0.008 105.290 -0.010
201806 0.043 106.317 0.055
201809 0.043 106.507 0.054
201812 0.035 105.998 0.045
201903 -0.912 107.251 -1.147
201906 0.018 108.070 0.022
201909 0.318 108.329 0.396
201912 0.018 108.420 0.022
202003 -0.009 108.902 -0.011
202006 -0.622 108.767 -0.772
202009 -0.034 109.815 -0.042
202012 -0.049 109.897 -0.060
202103 -0.025 111.754 -0.030
202106 0.158 114.631 0.186
202109 0.002 115.734 0.002
202112 -0.327 117.630 -0.375
202203 -0.163 121.301 -0.181
202206 -1.627 125.017 -1.756
202209 -0.242 125.227 -0.261
202212 -1.086 125.222 -1.170
202303 -0.299 127.348 -0.317
202306 -0.212 128.729 -0.222
202309 -0.628 129.860 -0.653
202312 -0.303 129.419 -0.316
202403 -0.202 131.776 -0.207
202406 -0.418 132.554 -0.425
202409 -0.036 133.029 -0.037
202412 0.248 133.157 0.251
202503 -0.009 134.927 -0.009

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioLife Solutions  (STU:BJX1) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


BioLife Solutions Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of BioLife Solutions's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLife Solutions Business Description

Traded in Other Exchanges
Address
3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

BioLife Solutions Headlines

No Headlines